Skip to main content

What is Treatment-Resistant Depression?


With strategies such as Transcranial Magnetic Stimulation (TMS), Ketamine, and psychedelics becoming more prevalent for treatment-resistant depression, it is helpful to take a look at what this entity really means. Not everyone who is being referred for either TMS or treatment with Ketamine may have "true" treatment-resistant depression, and then there is what is called "pseudo-resistance."

In simple terms, treatment-resistant depression implies that depression has not reached sufficient remission after adequate treatment. Remission is defined as clinical improvement with few signs of depression still remaining and a lower likelihood of subsequent exacerbations. About 15% of people with depression may eventually develop treatment-resistant depression (Berlim & Turecki, 2007). Treatment-resistant depression has been variously defined, but the most commonly accepted definition is as follows (Souery et al., 2007):

A person with depression is considered to have treatment-resistant depression when consecutive treatments with two antidepressants from two different pharmacologic classes, used for a sufficient length of time at an adequate dose, fail to produce significant improvement. This is further elaborated below:
  • Two different pharmacologic classes mean antidepressants have different mechanisms of action. For example, Selective Serotonin Reuptake Inhibitors (SSRIs) versus Serotonin Norepinephrine Reuptake Inhibitors (SNRIs).
  • An adequate length of time is an antidepressant trial lasting at least 4 weeks.
  • An adequate dose is the minimum effective daily dose recommended in the drug package insert.
  • Significant improvement is a score of less than 17 on the 17-item Hamilton Depression Rating Scale.
This definition of treatment-resistant depression has several problems. First, it assumes that switching from one class of antidepressants to another may be a more effective strategy than switching within the class. Second, it doesn’t discuss the role of psychotherapy. Third, it is silent on functional improvement and improvement in quality of life and relies only on clinical improvement to define treatment resistance. Nevertheless, this is the most accepted definition of treatment-resistant depression.

What is Pseudo-Resistance?
Before you jump the gun and diagnose yourself with treatment-resistant depression, first rule out if this is pseudo-resistance. About 60% of people initially classified as having treatment-resistant depression may actually have pseudo-resistance (Berlim & Turecki, 2007). The causes of pseudo-resistance are below (Berlim & Turecki, 2007; Souery et al., 2006):  

  1. Inadequate dosing of the antidepressants: This may be due to staying at a low dose of the antidepressants because of initial side effects that have subsequently abated. Other causes could be drug interactions that make the antidepressant less effective or an individual's rapid metabolism of the antidepressant. 
  2. Inadequate duration of the antidepressants: Switching medications too soon and concluding that a given medication is ineffective also contributes to pseudo-resistance.
  3. Inadequate adherence: Not taking the antidepressants as prescribed due to side effects or forgetting to take them accounts for about 20% of scenarios that are considered treatment-resistant depression.
  4. Improper diagnosis: This includes:
  • Failure to diagnose an underlying bipolar disorder.
  • Failure to diagnose psychotic symptoms associated with depression.
  • Failure to diagnose melancholic depression. Melancholic depression is a more severe kind of depression characterized by loss of pleasure in all, almost all activities, no emotional response when something good happens, a profound sense of despondency or despair, depression that is worse in the morning, early-morning awakening, appearing markedly slowed down or agitated, poor appetite or weight loss, and excessive or inappropriate guilt (American Psychiatric Association, 2013).
  • Failure to diagnose co-occurring anxiety or personality disorders.
  • Failure to identify underlying medical conditions that may be associated with depression, such as hypothyroidism.
If you haven’t responded to a couple of trials of antidepressants, it may be worthwhile to explore the above possibilities in collaboration with your antidepressant prescriber.

What are the Risk Factors for Treatment-Resistant Depression?
While there is no definitive cause as to why some people with depression will develop treatment-resistant depression, research does demonstrate certain risk factors that predispose one to develop treatment-resistant depression. These include the following (Souery et al., 2007):
  • Co-occurring anxiety disorders, particularly panic disorder and social phobia.
  • Having suicidal thoughts during the current episode of depression.
  • Greater severity of depressive symptoms.
  • Presence of melancholic symptoms of depression (described before).
  • History of recurrent episodes of depression.
  • More than one psychiatric hospitalization in the past.
  • Age of onset of depression before 18 years.
  • Non-response to the first antidepressant in one’s lifetime.
  • Co-occurring personality disorder.
Being aware of these risk factors helps an individual plan ahead for treatment as treatment-resistant depression may require a combination of medications or other non-pharmacological strategies.

To learn more about evidence-based self-management techniques that are proven to work for depression, check out Dr. Duggal's Author Page.


HARPREET S. DUGGAL, MD, FAPA

REFERENCES:

American Psychiatric Association (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Arlington, VA: American Psychiatric Association.

Berlim, M. T., & Turecki, G. (2007). Definition, assessment, and staging of treatment-resistant refractory major depression: a review of current concepts and methods. Canadian Journal of Psychiatry, 52, 46-54.

Souery, D., Oswald, P., Massat, I., Bailer, U., Bollen, J., Demyttenaere, K., Kasper, S., Lecrubier, Y., Montgomery, S., Serretti, A., Zohar, J., & Mendlewicz, J. for the Group for the Study of Resistant Depression (GSRD) (2007). Clinical factors associated with treatment resistance in major depressive disorder: results from a European multicenter study. Journal of Clinical Psychiatry, 68(7), 1062-1070.

Souery, D., Papakostas, G. I., & Trivedi, M. H. (2006). Treatment-resistant depression. Journal of Clinical Psychiatry, 67(suppl 6), 16-22.



Labels:

Comments

Post a Comment

Popular posts from this blog

7 Questions That Will Help You Overcome Anxiety, Fear and Panic

Anxiety, fear, and panic are associated with irrational thoughts involving themes of threat or danger. These irrational thoughts take the form of “if” or “what if” beliefs. For example, a person who is afraid of heights may think, “If I am on the elevator alone and it gets stuck, no one will be able to save me,” or a person with panic disorder may believe, “If my heart beats too fast, it means that I am probably having a heart attack.” The “if” and “what if” thinking in anxiety disorders is a byproduct of your irrational thought patterns, including magnification, catastrophizing, overgeneralizing, and “should” and “must statements.” Sometimes, anxiety is a result of genuine problems or situations that have no solutions. How does one then decide to challenge one's irrational thinking or problem-solve, or try acceptance strategies? The seven questions that will help you guide your decision to choose one path over another to overcome anxiety are as follows:  What is the likelihoo...
2 comments
Read more

Situational Analysis: An Effective Tool to Address Maladaptive Social Patterns in Chronic Depression

Approximately 30% of individuals with depressed mood develop a chronic course as defined by the criteria for persistent depressive disorder (PDD) (Struck et al., 2021). Research shows that depressed individuals have difficulties in handling another person's negative state or suffering, getting overwhelmed in emotionally tense situations, a condition called empathic distress. This leads to an avoidant interpersonal style due to fear of interaction with others, which in turn deprives these individuals of positive interpersonal experiences, thus perpetuating depressive symptoms (Struck et al., 2021). Situational analysis is a technique used in the Cognitive Behavioral Analysis System of Psychotherapy (CBASP). CBASP is one of the few psychotherapies effective for chronic depression and PDD (Wiersma et al., 2014; Wiersma et al., 2021). CBASP combines behavioral and cognitive strategies with a problem-solving focus and emphasizes interpersonal issues. Its primary goals are to help indivi...
Post a Comment
Read more

What Does it Really Mean to be Resilient?

What Constitutes Resilience? When adversity strikes, we are reminded to be "resilient." But what does it really mean to be resilient? For starters, resilience is not a single entity but a broad array of abilities for constructively and positively adapting to risk, adversity, or some monumental negative event (Dunn et al., 2009). Implicit within this definition are the two critical components of resilience – experiencing an adversity and a positive adaptation to it. Positive adaption has variously been defined, and the general consensus is that it connotes not only an absence or low levels of psychological symptoms (e.g., anxiety or depression) but also competence to meet societal and cultural expectations (Masten, 2001). The good news is that resilience is not a personality attribute that is fixed but is a dynamic process that individuals can develop (Luthar et al., 2000). In other words, no one is “born” or “naturally” resilient; it is something you learn and develop o...
Post a Comment
Read more